Metacare

At a glance

Metacare filed 44 disclosures in the last 12 months, including 3 insider, 3 5% holder, 2 issuance, 1 earnings and 1 m&a. The most recent key filing was on Oct 29: CEO bought 63,199 sh on the market at an average ₩1,286, Oct 22–28.

Revenue for 2025 was ₩32.8B, up 62.4% on 2024. Operating margin was 4% against 7.4% a year earlier. Debt was 64% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩18.9B and operating profit of ₩1.4B.

The 2025 annual report lists 32 employees with an average tenure of 3.1 years and average pay of ₩65.7M. Its 5 directors and auditors were paid ₩37.8M each on average. It paid no cash dividend for 2025. (주)메타랩스 and related parties held 37.28% at year end.

From the 2025 annual report

Staff: 32 (20 men, 12 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩2.1B. Directors and auditors: 5, paid ₩190.2M in total.

No cash dividend was paid for 2025.

Largest shareholder

(주)메타랩스 holds 37.28%; with 0 related parties the group holds 37.28% of common shares at year end (from 34.62% at the start of the year).

Auditor: 삼일회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary